Stanford phd candidate Calvin schmidt posts about investing opportunities in synthetic biology. Available for consulting on potential investments in this area.

Calvin Schmidt Synthetic Biology Index: May Update

Performance overview

Value at beginning of month: $156,861.08

Value at end of month: $140,475.45

Month over month change: -10.45%

Total IRR: 15.32%

Related indices, monthly change

NASDAQ: -8.51%

IVV (iShares Core S&P 500): -6.15%

IBB (iShares NASDAQ Biotechnology Index): -6.91%

MXI (iShares Global Materials): -7.57%

VEGI (iShares MSCI Global Agriculture Producers): -8.00%

ICLN (iShares Clean Energy): -1.28%

Individual performances

Kraig Biocraft Labs had a great performance in May off of several pieces of good news. Other than this company, most of the rest of the index had a poor showing to go along with a generally poor market. Agriculture companies were hit particularly hard, with Calyxt, Yield10, and Evogene all down 20% or more.

Changes made to index


You can view the index here.

Calvin Schmidt Synthetic Biology Index: June Update

Calvin Schmidt Synthetic Biology Index: April Update